insaneinsanity t1_iz0sea2 wrote on December 5, 2022 at 5:07 PM

Reply to comment by drunken-oracle in New type of surgical robot used to remove throat tumour by diacewrb

/shrugs/ Read the papers yourself.

https://pubmed.ncbi.nlm.nih.gov/34699271/

https://pubmed.ncbi.nlm.nih.gov/31416685/

https://www.sciencedirect.com/science/article/abs/pii/S0360301621028121

drunken-oracle t1_iz0uo6a wrote on December 5, 2022 at 5:22 PM

I read them but didn’t find anything about it.

ohaikthxbai t1_izab8uc wrote on December 7, 2022 at 5:19 PM

You're right because the articles don't support his claim see my post next to yours

insaneinsanity t1_iz0wb9l wrote on December 5, 2022 at 5:32 PM

You read the actual papers?

drunken-oracle t1_iz0wl26 wrote on December 5, 2022 at 5:34 PM

I read the abstracts you linked.

insaneinsanity t1_iz0zy29 wrote on December 5, 2022 at 5:55 PM

Yeah. That's why I said the papers. This is a complicated area of oncology and requires some in-depth knowledge.

[deleted] t1_iz127p7 wrote on December 5, 2022 at 6:09 PM

[deleted]

ohaikthxbai t1_izab64w wrote on December 7, 2022 at 5:18 PM

The OP's article seems to be talking about esophageal cancer not HPV related oropharynx.

ECOG 3311 demonstrates the value of robotic surgery in the deintensification of adjuvant therapy. Doesn't support your argument at all.

ORATOR 2 is a highly problematic trial - their two surgical arm mortalities were far more suggestive of issues with post-op care (in-hospital trach bleed) and surgical/radiation technique (spine infection AFTER radiation).

The surgeons in the ORATOR 2 trial had a morbidity profile that does not reflect any case series, trial, or database study based in the US. They were routinely doing tracheostomies, and they were not credentialing surgeons the way they did in E3311.

Personally the only useful information from the ORATOR 2 trial is: Don't get surgery with any of the surgeons who participated in the ORATOR 2 trial.